1. Home
  2. VALN vs NPKI Comparison

VALN vs NPKI Comparison

Compare VALN & NPKI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VALN
  • NPKI
  • Stock Information
  • Founded
  • VALN 2012
  • NPKI 1932
  • Country
  • VALN France
  • NPKI United States
  • Employees
  • VALN N/A
  • NPKI N/A
  • Industry
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • NPKI Metal Fabrications
  • Sector
  • VALN Health Care
  • NPKI Industrials
  • Exchange
  • VALN Nasdaq
  • NPKI Nasdaq
  • Market Cap
  • VALN 989.8M
  • NPKI 881.5M
  • IPO Year
  • VALN 2021
  • NPKI N/A
  • Fundamental
  • Price
  • VALN $8.63
  • NPKI $10.40
  • Analyst Decision
  • VALN Strong Buy
  • NPKI Strong Buy
  • Analyst Count
  • VALN 4
  • NPKI 3
  • Target Price
  • VALN $16.00
  • NPKI $12.17
  • AVG Volume (30 Days)
  • VALN 153.6K
  • NPKI 858.1K
  • Earning Date
  • VALN 08-12-2025
  • NPKI 08-05-2025
  • Dividend Yield
  • VALN N/A
  • NPKI N/A
  • EPS Growth
  • VALN N/A
  • NPKI N/A
  • EPS
  • VALN N/A
  • NPKI N/A
  • Revenue
  • VALN $230,566,060.00
  • NPKI $234,741,000.00
  • Revenue This Year
  • VALN $15.55
  • NPKI $19.94
  • Revenue Next Year
  • VALN $23.93
  • NPKI $9.36
  • P/E Ratio
  • VALN N/A
  • NPKI $21.42
  • Revenue Growth
  • VALN 25.47
  • NPKI 6.96
  • 52 Week Low
  • VALN $3.62
  • NPKI $4.76
  • 52 Week High
  • VALN $12.25
  • NPKI $10.51
  • Technical
  • Relative Strength Index (RSI)
  • VALN 46.03
  • NPKI 71.76
  • Support Level
  • VALN $8.71
  • NPKI $10.20
  • Resistance Level
  • VALN $9.05
  • NPKI $10.51
  • Average True Range (ATR)
  • VALN 0.46
  • NPKI 0.24
  • MACD
  • VALN -0.38
  • NPKI 0.02
  • Stochastic Oscillator
  • VALN 13.63
  • NPKI 86.63

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About NPKI NPK International Inc. Common Stock

NPK International Inc is a temporary worksite access solutions company that manufactures, sells, and rents recyclable composite matting products, along with a full suite of services, including planning, logistics, and site restoration. The company generates majority of revenue from the rental of recyclable composite matting systems, along with related site construction and services to customers in various markets including power transmission, oil and natural gas exploration and production, pipeline, renewable energy, petrochemical, construction and other industries within the United States and United Kingdom.

Share on Social Networks: